Currently set to Index
Currently set to Follow
search
ask age2b
CART 0

Continuous renal replacement therapy in intensive care patients with COVID-19; survival and renal recovery

By AGE2B team
October 12, 2021
0
0

Abstract

Outcome for critically ill patients with COVID-19 treated with continuous renal replacement therapy (CRRT) is largely unknown. This observational study was conducted at a university hospital in Sweden. There were studied critically ill adult COVID-19 patients with Acute Kidney injury (AKI) who received continuous renal replacement therapy.

In 451 patients,  Acute Kidney injury incidence was 43.7%. 18.2% received continuous renal replacement therapy. Median age of continuous renal replacement therapy patients was 60 years, 90% were male, median BMI was 29, 23.2% had Diabetes, 37.8% hypertension and 6.1% chronic kidney disease prior to admission. 100% required mechanical ventilation. 8.5% received Extra Corporeal Membrane Oxygenation. Median length of stay was 23 days. Critical patients in intensive care mortality was 39% and 90-day mortality was 45.1%. Age, baseline creatinine values and body weight change were associated with 60 days mortality. Of the survivors, no patients required dialysis at hospital discharge, 73.8% recovered renal function and a median 10.5% of body weight was lost during admission.

Conclusions: Critically ill COVID-19 patients with Acute Kidney injury who received continuous renal replacement therapy  had a 90-day mortality of 45.1%. At follow-up, three quarters of survivors had recovered renal function. This information is important in the clinical management of COVID-19 and further treatment for the critical patients.

Source ScienceDirect

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.